Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Common Stock Issued
Cash raised by issuing new shares.
Sionna Therapeutics, Inc.NASDAQ: SION
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued declines year over year
Q1 FY2026 common stock issued of $1.89M fell 99.1% year over year, behind the -97.4% change in trailing-twelve-month common stock issued. Sequentially, it rose 14.1% from the prior quarter.
Context
- Common stock issued increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -99.1% toward the trailing-twelve-month pace of -97.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 205.71M USD
- Year-over-year change
- +14.9%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 205.71M | +14.9% |
| FY2024 | 2024-12-31 | 178.97M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Common Stock Issued vs competitors
How SION compares with its peers on the latest reported figures
- SION's LTM Mar 2026 common stock issued of $5.21M is the smallest of the 11 companies compared; the peer median is $105.27M.
- Its year-over-year change of -97.4% is the 7th highest of 9, against a peer median of +18.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $432.8M | +90.2% | +2614.9% | — | |
| LTM Jun 2026 | $371.8M | +6.5% | -12.6% | — | |
| LTM Sep 2026 | $327.45M | +22878.8% | -16.3% | 292364.3% | |
| LTM Jun 2026 | $311.34M | -10.5% | +52.8% | — | |
| LTM Sep 2026 | $188.82M | — | — | 278.3% | |
| LTM Mar 2026 | $120.32M | -160.7% | +442.5% | 601.6% | |
| LTM Sep 2026 | $21.71M | +31.3% | -39.9% | 8.2% | |
| LTM Mar 2026 | $16.42M | — | -24.1% | 5.2% | |
| LTM Mar 2026 | $9.8M | +53.2% | -56.6% | 2.3% | |
| LTM Mar 2026 | $7.94M | -97.9% | +119.6% | 36.7% | |
| LTM Mar 2026 | $5.21M | -97.4% | — | — | |
| Peer median (excluding SION) | $105.27M | +18.9% | -12.6% | 36.7% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.